Update Breast Cancer 2023 Part 3-Expert Opinions of Early Stage Breast Cancer Therapies

被引：2

作者：

Kolberg, Hans-Christian ^{[1
]}

Hartkopf, Andreas D. ^{[2
]}

Fehm, Tanja N. ^{[3
]}

Welslau, Manfred ^{[4
]}

Mueller, Volkmar ^{[5
]}

Schuetz, Florian ^{[6
]}

Fasching, Peter A. ^{[7
]}

Janni, Wolfgang ^{[2
]}

Witzel, Isabell ^{[8
]}

Thomssen, Christoph ^{[9
]}

Beierlein, Milena ^{[7
]}

Belleville, Erik ^{[10
]}

Untch, Michael ^{[11
]}

Thill, Marc ^{[12
]}

Tesch, Hans ^{[13
]}

Ditsch, Nina ^{[14
]}

Lux, Michael P. ^{[15
,16
,17
]}

Aktas, Bahriye ^{[18
]}

Banys-Paluchowski, Maggie ^{[19
]}

Kolberg-Liedtke, Cornelia ^{[20
]}

Woeckel, Achim ^{[21
]}

Harbeck, Nadia ^{[22
,23
]}

Stickeler, Elmar ^{[24
,25
]}

Bartsch, Rupert ^{[26
]}

Schneeweiss, Andreas ^{[27
]}

Ettl, Johannes ^{[28
,29
]}

Krug, David ^{[30
]}

Taran, Florin-Andrei ^{[31
]}

Lueftner, Diana ^{[32
,33
]}

Wuerstlein, Rachel

机构：

[1] Marienhosp Bottrop, Dept Gynecol & Obstet, Bottrop, Germany

[2] Ulm Univ Hosp, Dept Gynecol & Obstet, Ulm, Germany

[3] Univ Hosp Dusseldorf, Dept Gynecol & Obstet, Dusseldorf, Germany

[4] Onkol Aschaffenburg, Aschaffenburg, Germany

[5] Hamburg Eppendorf Univ Med Ctr, Dept Gynecol, Hamburg, Germany

[6] Diakonissen Stiftungs Krankenhaus Speyer, Gynakol & Geburtshilfe, Speyer, Germany

[7] Friedrich Alexander Univ Erlangen Nuremberg, Comprehens Canc Ctr Erlangen EMN, Erlangen Univ Hosp, Dept Gynecol & Obstet, Univ Str 21-23, D-91054 Erlangen, Germany

[8] Univ Spital Zurich, Klin Gynakol, Zurich, Switzerland

[9] Martin Luther Univ Halle Wittenberg, Dept Gynaecol, Halle, Saale, Germany

[10] ClinSol GmbH & Co KG, Wurzburg, Germany

[11] Helios Klinikum Berlin Buch, Breast Canc Ctr, Gynecol Oncol Ctr, Clin Gynecol & Obstet, Berlin, Germany

[12] Agaples Markus Krankenhaus, Dept Gynecol & Gynecol Oncol, Frankfurt, Germany

[13] Bethanien Hosp, Oncol Practice, Frankfurt, Germany

[14] Univ Hosp Augsburg, Dept Gynecol & Obstet, D-86156 Augsburg, Germany

[15] Frauenklin St Louise, Klin Gynakol & Geburtshilfe, Paderborn, Germany

[16] St Josefs Hosp, Salzkotten, Germany

[17] St Vincenz Krankenhaus GmbH, Paderborn, Germany

[18] Univ Leipzig, Med Ctr, Dept Gynecol, Leipzig, Germany

[19] Univ Hosp Schleswig Holstein, Dept Gynecol & Obstet, Campus Lubeck, Lubeck, Germany

[20] Univ Hosp Essen, Dept Gynecol & Obstet, Essen, Germany

[21] Univ Hosp Wurzburg, Dept Gynecol & Obstet, D-97080 Wurzburg, Germany

[22] LMU Univ Hosp, Breast Ctr, Dept Gynecol & Obstet, Munich, Germany

[23] LMU Univ Hosp, CCC Munich LMU, Munich, Germany

[24] Ctr Integrated Oncol CIO Aachen, Dept Obstet & Gynecol, Aachen, Germany

[25] Univ Hosp RWTH Aachen, Aachen, Germany

[26] Med Univ Vienna, Dept Med 1, Div Oncol, Vienna, Austria

[27] Univ Hosp Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany

[28] German Canc Res Ctr, Heidelberg, Germany

[29] Klinikum Kempten, Klin Frauenheilkunde & Gynakol, Klin Verbund Allgau, Kempten, Germany

[30] Univ Klinikum Schleswig Holstein, Klin Strahlentherapie, Campus Kiel, Kiel, Germany

[31] Univ Hosp Freiburg, Dept Gynecol & Obstet, Freiburg, Germany

[32] Immanuel Hosp Markische Schweiz, Buckow, Germany

[33] Med Univ Brandenburg Theodor Fontane, Brandenburg, Germany

来源：

GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 09期

关键词：

breast cancer; therapy recommendation; chemotherapy; endocrine therapy; EXTENDED ADJUVANT THERAPY; ENDOCRINE THERAPY; FREE SURVIVAL; PRIMARY TUMOR; DOUBLE-BLIND; OPEN-LABEL; TAMOXIFEN; NERATINIB; MULTICENTER; METASTASES;

D O I：

10.1055/a-2143-8125

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The St. Gallen (SG) International Breast Cancer Conference is held every two years, previously in St. Gallen and now in Vienna. This year (2023) marks the eighteenth edition of this conference, which focuses on the treatment of patients with early-stage breast carcinoma. A panel discussion will be held at the end of this four-day event, during which a panel of experts will give their opinions on current controversial issues relating to the treatment of early-stage breast cancer patients. To this end, questions are generally formulated in such a way that clinically realistic cases are presented - often including poignant hypothetical modifications. This review reports on the outcome of these discussions and summarises the data associated with individual questions raised.

引用

页码：1117 / 1126

页数：10

共 60 条

[1] Treatment of the primary tumor in breast cancer patients with synchronous metastases [J].

Ali, D. ;

Le Scodan, R. .

ANNALS OF ONCOLOGY, 2011, 22 (01) :9-16

[2] Management of patients with early-stage triple-negative breast cancer following pembrolizumab-based neoadjuvant therapy: What are the evidences? [J].

Bonadio, Renata Colombo ;

Tarantino, Paolo ;

Testa, Laura ;

Punie, Kevin ;

Pernas, Sonia ;

Barrios, Carlos ;

Curigliano, Giuseppe ;

Tolaney, Sara M. ;

Barroso-Sousa, Romualdo .

CANCER TREATMENT REVIEWS, 2022, 110

[3] 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer [J].

Cardoso, F. ;

van't Veer, L. J. ;

Bogaerts, J. ;

Slaets, L. ;

Viale, G. ;

Delaloge, S. ;

Pierga, J. -Y. ;

Brain, E. ;

Causeret, S. ;

DeLorenzi, M. ;

Glas, A. M. ;

Golfinopoulos, V. ;

Goulioti, T. ;

Knox, S. ;

Matos, E. ;

Meulemans, B. ;

Neijenhuis, P. A. ;

Nitz, U. ;

Passalacqua, R. ;

Ravdin, P. ;

Rubio, I. T. ;

Saghatchian, M. ;

Smilde, T. J. ;

Sotiriou, C. ;

Stork, L. ;

Straehle, C. ;

Thomas, G. ;

Thompson, A. M. ;

van der Hoeven, J. M. ;

Vuylsteke, P. ;

Bernards, R. ;

Tryfonidis, K. ;

Rutgers, E. ;

Piccart, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (08) :717-729

[4] Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial [J].

Chan, Arlene ;

Moy, Beverly ;

Mansi, Janine ;

Ejlertsen, Bent ;

Holmes, Frankie Ann ;

Chia, Stephen ;

Iwata, Hiroji ;

Gnant, Michael ;

Loibl, Sibylle ;

Barrios, Carlos H. ;

Somali, Isil ;

Smichkoska, Snezhana ;

Martinez, Noelia ;

Alonso, Mirta Garcia ;

Link, John S. ;

Mayer, Ingrid A. ;

Cold, Soren ;

Murillo, Serafin Morales ;

Senecal, Francis ;

Inoue, Kenichi ;

Ruiz-Borrego, Manuel ;

Hui, Rina ;

Denduluri, Neelima ;

Patt, Debra ;

Rugo, Hope S. ;

Johnston, Stephen R. D. ;

Bryce, Richard ;

Zhang, Bo ;

Xu, Feng ;

Wong, Alvin ;

Martin, Miguel .

CLINICAL BREAST CANCER, 2021, 21 (01) :80-+

[5] Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial [J].

Chan, Arlene ;

Delaloge, Suzette ;

Holmes, Frankie A. ;

Moy, Beverly ;

Iwata, Hiroji ;

Harvey, Vernon J. ;

Robert, Nicholas J. ;

Silovski, Tajana ;

Gokmen, Erhan ;

von Minckwitz, Gunter ;

Ejlertsen, Bent ;

Chia, Stephen K. L. ;

Mansi, Janine ;

Barrios, Carlos H. ;

Gnant, Michael ;

Buyse, Marc ;

Gore, Ira ;

Smith, John, II ;

Harker, Graydon ;

Masuda, Norikazu ;

Petrakova, Katarina ;

Guerrero Zotano, Angel ;

Iannotti, Nicholas ;

Rodriguez, Gladys ;

Tassone, Pierfrancesco ;

Wong, Alvin ;

Bryce, Richard ;

Ye, Yining ;

Yao, Bin ;

Martin, Miguel .

LANCET ONCOLOGY, 2016, 17 (03) :367-377

[6] Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer [J].

Couch, Fergus J. ;

Hart, Steven N. ;

Sharma, Priyanka ;

Toland, Amanda Ewart ;

Wang, Xianshu ;

Miron, Penelope ;

Olson, Janet E. ;

Godwin, Andrew K. ;

Pankratz, V. Shane ;

Olswold, Curtis ;

Slettedahl, Seth ;

Hallberg, Emily ;

Guidugli, Lucia ;

Davila, Jaime I. ;

Beckmann, Matthias W. ;

Janni, Wolfgang ;

Rack, Brigitte ;

Ekici, Arif B. ;

Slamon, Dennis J. ;

Konstantopoulou, Irene ;

Fostira, Florentia ;

Vratimos, Athanassios ;

Fountzilas, George ;

Pelttari, Liisa M. ;

Tapper, William J. ;

Durcan, Lorraine ;

Cross, Simon S. ;

Pilarski, Robert ;

Shapiro, Charles L. ;

Klemp, Jennifer ;

Yao, Song ;

Garber, Judy ;

Cox, Angela ;

Brauch, Hiltrud ;

Ambrosone, Christine ;

Nevanlinna, Heli ;

Yannoukakos, Drakoulis ;

Slager, Susan L. ;

Vachon, Celine M. ;

Eccles, Diana M. ;

Fasching, Peter A. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (04) :304-U154

[7] Comparison of Models to Predict Nonsentinel Lymph Node Status in Breast Cancer Patients With Metastatic Sentinel Lymph Nodes: A Prospective Multicenter Study [J].

Coutant, Charles ;

Olivier, Camille ;

Lambaudie, Eric ;

Fondrinier, Eric ;

Marchal, Frederic ;

Guillemin, Francois ;

Seince, Nathalie ;

Thomas, Veronique ;

Leveque, Jean ;

Barranger, Emmanuel ;

Darai, Emile ;

Uzan, Serge ;

Houvenaeghel, Gilles ;

Rouzier, Roman .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (17) :2800-2808

[8]

Croessmann S, 2021, CLIN ADV HEMATOL ONC, V19, P155

[9] Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer A Systematic Review and Meta-analysis [J].

Cullinane, Carolyn ;

Fleming, Christina ;

O'Leary, Donal Peter ;

Hassan, Fara ;

Kelly, Louise ;

O'Sullivan, Martin J. ;

Corrigan, Mark Antony ;

Redmond, Henry Paul .

JAMA NETWORK OPEN, 2020, 3 (11)

[10] Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial [J].

Davies, Christina ;

Pan, Hongchao ;

Godwin, Jon ;

Gray, Richard ;

Arriagada, Rodrigo ;

Raina, Vinod ;

Abraham, Mirta ;

Medeiros Alencar, Victor Hugo ;

Badran, Atef ;

Bonfill, Xavier ;

Bradbury, Joan ;

Clarke, Michael ;

Collins, Rory ;

Davis, Susan R. ;

Delmestri, Antonella ;

Forbes, John F. ;

Haddad, Peiman ;

Hou, Ming-Feng ;

Inbar, Moshe ;

Khaled, Hussein ;

Kielanowska, Joanna ;

Kwan, Wing-Hong ;

Mathew, Beela S. ;

Mittra, Indraneel ;

Mueller, Bettina ;

Nicolucci, Antonio ;

Peralta, Octavio ;

Pernas, Fany ;

Petruzelka, Lubos ;

Pienkowski, Tadeusz ;

Radhika, Ramachandran ;

Rajan, Balakrishnan ;

Rubach, Maryna T. ;

Tort, Sera ;

Urrutia, Gerard ;

Valentini, Miriam ;

Wang, Yaochen ;

Peto, Richard .

LANCET, 2013, 381 (9869) :805-816

← 1 2 3 4 5 6 →